-
into risk genes and molecular mechanisms in Frontotemporal Dementia (FTD), while the Sleegers lab specializes in Alzheimer’s Disease (AD), both leveraging next-generation sequencing and innovative
-
EXAFS) and high-resolution Raman and diffuse reflectance infrared Fourier transform spectroscopy (DRIFTS) to unravel charge transfer mechanisms, active sites and intermediate molecules in the reaction
-
strategies, with a focus on singlet oxygen production and suppression in photoelectrochemistry and sensing applications. By evaluating different quenching mechanisms (e.g., proximity-based singlet oxygen
-
. By evaluating different quenching mechanisms (e.g., proximity-based singlet oxygen quenching and wavelength-specific energy transfer), this project seeks to develop novel insights into molecular